Henry Schein, Inc. is rated a Buy as signs of improving growth and undervaluation emerge despite recent stagnation. Click for ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Shares of Henry Schein Inc. HSIC slid 3.21% to $77.60 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and Dow ...

Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 4.8% in the afternoon session after the company reported decent fourth-quarter 2025 financial results where revenue ...

Q2 EPS of $1.10 missed estimates by $0.10; revenue rose 3.3% to $3.34 billion, topping expectations. The company sees over $100 million in annual savings from restructuring, affirms 2025 EPS and ...

On September 9, a recent SEC filing unveiled that Lorelei McGlynn, SVP at Henry Schein (NASDAQ:HSIC) made an insider sell. What Happened: McGlynn's recent Form 4 filing with the U.S. Securities and ...

I have always appreciated companies with interesting business models or that cater to interesting markets. That's why, at least on a conceptual level, I really like Henry Schein, Inc. (HSIC). For ...

We recently compiled a list of the 10 Best Mid Cap Value Stocks To Invest In. In this article, we are going to take a look at where Henry Schein, Inc. (NASDAQ:HSIC) stands against the other best mid ...